EMA Updates Guidance on PK Evaluations, BE Study Requirements

Drug Industry Daily
A A
Drugmakers may use pharmacokinetic bioequivalence studies to compare how two orally-inhaled drugs with the same active substance disperse in the lungs, the European Medicines Agency says.

To View This Article:

Login

Subscribe To Drug Industry Daily